US 12,440,495

Application 18/383,992 · Granted Oct 14, 2025

Combination therapy for treatment of myeloproliferative neoplasms

Estimated expiration

June 2, 2041

14y 197d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Jun 2, 2021
+ 20 years
Jun 2, 2041
PTA +0d
Jun 2, 2041
TD cap (US 11,833,155)
Feb 11, 2042
Final
Jun 2, 2041

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
October 26, 2023
Earliest effective filing
June 2, 2021
Issue date
October 14, 2025
PTA
0 days
Base expiry (before PTA)
June 2, 2041

June 2, 2021 + 20 years = June 2, 2041

  • Continuation of application 17/337,006, filed Jun 2, 2021, issued as US 11,833,155
  • PRO63/078,123 — Provisional — not used for base term
  • PRO63/034,214 — Provisional — not used for base term
  • PRO63/034,214 — Provisional — not used for base term
  • PRO63/078,123 — Provisional — not used for base term

Terminal disclaimers

TD approved1 approved, 1 filed

TD caps expiration to February 11, 2042 (earliest expiring referenced patent: US 11,833,155)

  • US 11,833,155· Application 17/337,006Capping patent

    Combination therapy for treatment of myeloproliferative neoplasms

    Filing date
    Jun 2, 2021
    Earliest effective filing
    Jun 2, 2021
    Issue date
    Dec 5, 2023
    PTA
    +254 days
    Calculated expiration
    Feb 11, 2042

    Jun 2, 2021 + 20y + 254d PTA = Feb 11, 2042

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 18/383,992 · US 12,440,495

PatentReply compiles the prosecution history behind US 12,440,495: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12440495

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.